Technical Analysis for DMTK - DermTech, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Pocket Pivot | Bullish Swing Setup | -2.64% | |
Wide Bands | Range Expansion | -2.64% | |
New 52 Week Closing Low | Bearish | 6.20% | |
New 52 Week Low | Weakness | 6.20% | |
Wide Bands | Range Expansion | 6.20% | |
Down 3 Days in a Row | Weakness | 6.20% | |
Oversold Stochastic | Weakness | 6.20% | |
Wide Bands | Range Expansion | 4.59% | |
Oversold Stochastic | Weakness | 4.59% | |
Wide Bands | Range Expansion | 1.13% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 1 hour ago |
10 DMA Support | about 1 hour ago |
60 Minute Opening Range Breakdown | about 1 hour ago |
Down 5% | about 1 hour ago |
Down 3% | about 2 hours ago |
Get a Trading Assistant
- Earnings date: 05/02/2024
DermTech, Inc. Description
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
Classification
Sector: Industrials
Industry: Conglomerates
Keywords: Medicine Cancer Melanoma Dermatology Gene Expression Diagnostic Tests Risk Assessment Pathology Biopsy Skin Cancer Assessment Products Melanoma Skin Cancer Pigmented Lesion Cutaneous Conditions Non Melanoma Skin Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.66 |
52 Week Low | 0.6229 |
Average Volume | 340,643 |
200-Day Moving Average | 1.77 |
50-Day Moving Average | 1.06 |
20-Day Moving Average | 0.74 |
10-Day Moving Average | 0.68 |
Average True Range | 0.08 |
RSI (14) | 35.90 |
ADX | 37.6 |
+DI | 13.29 |
-DI | 28.55 |
Chandelier Exit (Long, 3 ATRs) | 1.16 |
Chandelier Exit (Short, 3 ATRs) | 0.86 |
Upper Bollinger Bands | 1.03 |
Lower Bollinger Band | 0.46 |
Percent B (%b) | 0.44 |
BandWidth | 75.97 |
MACD Line | -0.13 |
MACD Signal Line | -0.14 |
MACD Histogram | 0.0162 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.83 | ||||
Resistance 3 (R3) | 0.81 | 0.76 | 0.81 | ||
Resistance 2 (R2) | 0.76 | 0.73 | 0.77 | 0.80 | |
Resistance 1 (R1) | 0.74 | 0.71 | 0.75 | 0.75 | 0.79 |
Pivot Point | 0.68 | 0.68 | 0.69 | 0.69 | 0.68 |
Support 1 (S1) | 0.66 | 0.65 | 0.67 | 0.67 | 0.62 |
Support 2 (S2) | 0.61 | 0.63 | 0.61 | 0.62 | |
Support 3 (S3) | 0.58 | 0.61 | 0.61 | ||
Support 4 (S4) | 0.59 |